Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination antiretroviral therapy

American Journal of Medicine

Volumn 108, Issue 3, 2000, Pages 249-251

  Proia, Laurie A ^a   Ngui, Siew Lin ^a   Kaur, Suman ^a   Kassler, Harold A ^a   Trenholme, Gordon M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; STAVUDINE; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS REACTIVATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALANINE TRANSAMINASE; ANTI-HIV AGENTS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; DRUG THERAPY, COMBINATION; HEPATITIS B; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RNA, VIRAL;

EID: 0343314887     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00437-4     Document Type: Article

References (10)

1. Carr A, Cooper DA. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet. 1997;349:995-996.
2. Locarnini SA. Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance. Hepatology. 1998;27:294-297.
3. Race EM, Adelson-Mitty J, Kriegal GR, et al. Focal mycobacterial lymphadenitis following initiation of protease inhibitor therapy in patients with advanced HIV-1 disease. Lancet. 1998;351:252-255.
4. th World AIDS Conference, Geneva, 1998. Abstract 22323.
5. th World AIDS Conference, Geneva, 1998. Abstract 22240.
6. Zylberberg H, Pialoux G, Carnot F, et al. Rapidly evolving hepatitis C virus related cirrhosis in a human immunodeficiency virus infected patient receiving triple antiretroviral therapy. Clin Infect Dis. 1998;27:1255-1257.
7. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest. 1997; 99:1472-1477.
8. Lederman MM, Connick E, Landay A, et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS clinical trials group protocol 315. J Infect Dis. 1998;178:70-79.
9. Vento S, Garofano T, Renzini C, et al. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. AIDS. 1998;12:116-117.
10. Hoofhagle JH, DiBisceglie AM. The treatment of chronic viral hepatitis. NEJM. 1997;336:347-356.